content

CordenPharma Expands Early Clinical Peptide Manufacturing to Launch IND-Targeted Peptide API to Injectable Drug Product Integrated Offer

After an initial expansion of the CordenPharma Frankfurt site for non-GMP manufacturing in 2020, and because of sustained success and exemplary performance delivered by...

New Treatment For Endometrial Cancer Gets Clearance From NHS

The NHS is all set to come up with groundbreaking immunotherapy that can go on to potentially offer a significant additional time when it...

Better Outcomes On Crohns Disease Treatment – UK Research

Top-down treatment by way of infliximab Plus, which is an immunomodulator, goes on to substantially enhance the outcomes for patients with newly diagnosed Crohn’s...

Cresset Increases Its North America Presence with New Boston Site

Cresset, a provider of integrated in silico solutions for drug discovery has expanded its existing North American presence, with the creation of a new...

Bachem in conversation with ChromaCon founders

While they were visiting Bachem, we had the chance to sit down and talk with Prof. Massimo Morbidelli, Dr. Lars Aumann, and Dr. Thomas...

One of Northern Europe’s Largest Production Sites successfully taken over by the Prange Group and Adragos Pharma

The Prange Group and its affiliate Adragos Pharma, one of Europe’s fastest growing CDMOs, has completed the acquisition transaction of Fresenius Kabi production site...

Pharma and Biotech’s Green Revolution

At its core the production of life-saving medicines for patients all over the world is meaningful and sustainable. Yet, there is still a considerable...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read